NEURO2026

*Ryohei Uenishi¹, Masanori Hijioka², Rinna Kawata², Tatsuya Manabe², Takashi Saito² (1. Dept. of Neurocognitive Sci., Nagoya City Univ., Japan, 2. Dept. of Neuropathology, Univ. of Tokyo, Tokyo, Japan)

*Maria Kano^1,4, Taeko Kimura¹, Haruaki Yanagisawa², Lisa Tatsumi¹, Komei Yamashita¹, Asahi Sakai¹, Xinyi Li¹, Takaomi C Saido³, Takashi Saito², Sho Takatori¹, Masahide Kikkawa², Koji Yamanaka⁴, Taisuke Tomita¹ (1. Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan, 2. Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 3. RIKEN Center for Brain Science, Saitama, Japan , 4. Research Institute of Environmental Medicine, Nagoya University, Aichi, Japan)

*Kentaro Gejima¹, Yutaka Oji¹, Ryo Wakamori¹, Eriko Igami¹, Junji Yamaguchi², Mitsuhiro Kitagawa¹, Yoko Imamichi¹, Risa Nonaka^3,4, Masaya Imoto¹, Wado Akamatsu⁴, Taku Hatano¹, Nobutaka Hattori^1,5 (1. Department of Neurology, Juntendo University School of Medicine, 2. Laboratory of Morphology and Image Analysis, Juntendo University, 3. Juntendo University Faculty of Pharmacy , 4. Center of Genomic and Regeneration Medicine, Juntendo University, 5. Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science)

*Ching Chi Jimmy He¹, Kishi Noriyuki², Tsukasa Sanosaka¹, Hideyuki Okano³, Jun Kohyama⁴ (1. Keio University Graduate School Physiology Department, 2. RIKEN CBS, 3. Keio University Regenerative Medicine Research Center, 4. Waseda University Faculty of Human Sciences Laboratory of Stem Cell Biology)